Fidelity International
HCAT icon

Fidelity International’s Health Catalyst HCAT Stock Holding History

Fidelity International’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-112,572
Closed -$4.46M – 849
2021
Q4 		$4.46M Buy
112,572
+602
+0.5% +$27.4K ﹤0.01% 618
2021
Q3 		$5.6M Buy
111,970
+7,063
+7% +$385K 0.01% 588
2021
Q2 		$5.82M Sell
104,907
-3,546
-3% -$189K 0.01% 627
2021
Q1 		$5.07M Buy
108,453
+2,989
+3% +$145K 0.01% 599
2020
Q4 		$4.59M Sell
105,464
-135,969
-56% -$5.02M 0.01% 555
2020
Q3 		$8.84M Buy
+241,433
New +$8.2M 0.01% 497

Other funds holding HCAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fidelity International's HCAT Position: Q1 2022 in Review

Fidelity International sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 112,572 shares — an estimated $4.46M sold.

Fidelity International first reported a position in HCAT in Q3 2020 and held it in 6 quarters. The position peaked at $8.84M in Q3 2020. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.

  • Fidelity International reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
  • Fidelity International sold 112,572 Health Catalyst shares in Q1 2022, an estimated $4.46M.
  • Fidelity International first reported a position in Health Catalyst in Q3 2020 and held it in 6 quarters.
  • Fidelity International's Health Catalyst position peaked at $8.84M in Q3 2020.
  • 185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.

Based on Fidelity International's 13F filing for Q1 2022, filed 13 May 2022.